Literature DB >> 12453637

Characterization of a sialate pyruvate-lyase in the cytosol of human erythrocytes.

Tatiana Bulai1, Daniela Bratosin, Vlad Artenie, Jean Montreuil.   

Abstract

Sialate pyruvate-lyases, also known as sialate aldolases (EC 4.1.3.3), reversibly catalyse the cleavage of free N-acetylneuraminic acids to form pyruvate and N-acetylmannosamine. These enzymes are widely distributed and are present in numerous pro- and eukaryotic cells, in which they are localized only in the cytosol. They play an important role in the regulation of sialic acid metabolism by controlling the intracellular concentration of sialic acids of biosynthetic or exogenous origin, thus preventing the accumulation of toxic levels of this sugar. Application of an original colorimetric micromethod for N-acetylmannosamine determination, as well as the use of [4,5,6,7,8,9-14C]N-acetylneuraminic acid, led us to evidence a cytosolic neuraminate aldolase activity in human red blood cells (RBCs) and then to define the main characteristics of this enzyme: Michaelis-Menten type, K(m:) 1.4 +/- 0.05 mM, optimal pH: 7.6 +/- 0.2, optimal temperature: 70 +/- 2 degrees C, inhibition by heavy metals: Ag(+) and Hg(++). These enzyme parameters are close to those of the bacterial and mammalian aldolases described up to now. At the moment, the presence of sialate pyruvate-lyase in the cytosol of red blood cells remains an enigma. Copyright 2002 Société françcaise de biochimie et biologie moléculaire / Editions scientifiques et médicales Elsevier SAS

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453637     DOI: 10.1016/s0300-9084(02)01436-0

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs.

Authors:  Shinji Go; Chihiro Sato; Kimio Furuhata; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

2.  Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamine.

Authors:  Anne K Bergfeld; Oliver M T Pearce; Sandra L Diaz; Roger Lawrence; David J Vocadlo; Biswa Choudhury; Jeffrey D Esko; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

3.  Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid.

Authors:  Anne K Bergfeld; Oliver M T Pearce; Sandra L Diaz; Tho Pham; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

4.  The capability of catabolic utilization of N-acetylneuraminic acid, a sialic acid, is essential for Vibrio vulnificus pathogenesis.

Authors:  Hee Gon Jeong; Man Hwan Oh; Byoung Sik Kim; Min Young Lee; Ho Jae Han; Sang Ho Choi
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

5.  N-glycolyl groups of nonhuman chondroitin sulfates survive in ancient fossils.

Authors:  Anne K Bergfeld; Roger Lawrence; Sandra L Diaz; Oliver M T Pearce; Darius Ghaderi; Pascal Gagneux; Meave G Leakey; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

6.  Alterations of the Erythrocyte Membrane during Sepsis.

Authors:  Yasmina Serroukh; Sarah Djebara; Christophe Lelubre; Karim Zouaoui Boudjeltia; Patrick Biston; Michael Piagnerelli
Journal:  Crit Care Res Pract       Date:  2012-05-21

7.  Glycosylation of erythrocyte spectrin and its modification in visceral leishmaniasis.

Authors:  Sajal Samanta; Devawati Dutta; Angana Ghoshal; Sumi Mukhopadhyay; Bibhuti Saha; Shyam Sundar; Saulius Jarmalavicius; Michael Forgber; Chhabinath Mandal; Peter Walden; Chitra Mandal
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  Unified theory of bacterial sialometabolism: how and why bacteria metabolize host sialic acids.

Authors:  Eric R Vimr
Journal:  ISRN Microbiol       Date:  2013-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.